Marie‐Christine Etienne

Author

Centre Antoine Lacassagne

Also Known As

Marie-Christine Etienne, Marie‐Christine Etienne, Marie–Christine Etienne

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Centre Antoine Lacassagne Inserm Centre Hospitalier Universitaire de Grenoble Institut Paoli-Calmettes Hôpital Paul-Brousse

About

Marie‐Christine Etienne is an author at Centre Antoine Lacassagne specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	471
2	Biochemistry	6	6	189
3	Natural Sciences	3	3	68
4	Health Sciences	2	2	79
5	Cell Biology	1	1	63

Marie‐Christine Etienne

Publications

Citations

H-Index

Page 1

	Year	Citations
Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic Analyses Marie‐Christine Etienne, M Chazal, Pierre Laurent‐Puig, Journal of Clinical Oncology	2002	176
Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients Marie‐Christine Etienne, Jean–Louis Formento, M Chazal, Pharmacogenetics Optimal Fluoropyrimidine EfficacyFluorouracil-based TreatmentOncogenic AgentMedicineGenetics	2004	132
Age-related difference in tamoxifen disposition F. Peyrade, Marc Frénay, Marie‐Christine Etienne, Clinical Pharmacology & Therapeutics	1996	79
Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity Valérie Pavillard, Patricia Formento, Philippe Rostagno, Biochemical Pharmacology Drug ActivityPharmaceutical ScienceDrug AnalysisBiochemistryMedicine	1998	69
Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer G. Metzger, Claire Massari, Marie‐Christine Etienne, Clinical Pharmacology & Therapeutics	1994	68
Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice Elisabeth Filipski, Verdun M. King, Marie‐Christine Etienne, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology Cortisol RhythmsHomeostatic MechanismHematologyBone MarrowHealth Sciences	2004	63
ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine. Nicolas Magné, Jean–Louis Fischel, A Dubreuil, PubMed	2003	54
Prognostic value of total cathepsin D in breast tumors Moïse Namer, A. Ramaioli, Xavier Fontana, Breast Cancer Research and Treatment Breast OncologyMedicinePathologyBreast CancerOncology	1991	54
Determination of microsatellite instability,p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: Relationship with response to 5-fluorouracil and survival Christophe Rosty, M Chazal, Marie‐Christine Etienne, International Journal of Cancer	2001	51
Depressed hepatic dihydropyrimidine dehydrogenase activity and fluorouracil-related toxicities François Stéphan, Marie‐Christine Etienne, Claudy Wallays, The American Journal of Medicine Fluorouracil-related ToxicitiesBiochemistryMedicineLiver PhysiologyToxicology	1995	37

Page 1